Advanced search
Publication Cover
Leukemia & Lymphoma Volume 15, 1994 - Issue 1-2
Submit an article Journal homepage
30
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Effect of Granulocyte Colony-Stimulating Factor in Patients with Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy

Agustin Avilés Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
,
Jose C. Díaz-Maqueo Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
,
Alejandra Talavera Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
,
M. Jesús Nambo Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
&
Edna L. García Department of Hematology Oncology Hospital, National Medical Center, Mexico, DF, Mexico
Pages 153-157 | Received 10 Oct 1993, Published online: 01 Jul 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Gerard B. Donnelly, Jill Glassman, Carol Long, Pilar Torres, David J. Straus, James P. O'brien, Joseph Bertino, Craig H. Moskowitz, Andrew D. Zelenetz & Carol S. Portlock. (2000) Granulocyte-Colony Stimulating Factor (G-CSF) May Improve Disease Outcome in Elderly Patients with Diffuse Large Cell Lymphoma (DLCL) Treated with CHOP Chemotherapy. Leukemia & Lymphoma 39:1-2, pages 67-75.
Read now
Dawn N. Saxon, Lawrence D. Mayer & Marcel B. Bally. (1999) Liposomal Anticancer Drugs as Agents to be used in Combination with other Anticancer Agents: Studies on a Liposomal Formulation with two Encapsulated Drugs. Journal of Liposome Research 9:4, pages 507-522.
Read now

Articles from other publishers (9)

J.J. Vehreschild, A. Böhme, O.A. Cornely, C. Kahl, M. Karthaus, K.-A. Kreuzer, G. Maschmeyer, S. Mousset, V. Ossendorf, O. Penack, M.J.G.T. Vehreschild & J. Bohlius. (2014) Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy—evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO). Annals of Oncology 25:9, pages 1709-1718.
Crossref
Julia Bohlius, Christine Herbst, Marcel Reiser, Guido Schwarzer & Andreas Engert. (2008) Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma. Cochrane Database of Systematic Reviews.
Crossref
A R Clamp, W D J Ryder, S Bhattacharya, R Pettengell & J A Radford. (2008) Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma. British Journal of Cancer 99:2, pages 253-258.
Crossref
A Hackshaw, J Sweetenham & A Knight. (2004) Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?. British Journal of Cancer 90:7, pages 1302-1305.
Crossref
Antonio Pagliuca, Patrick A. Carrington, Ruth Pettengell, Simon Rule & Jane Keidan. (2003) Guidelines on the use of colony-stimulating factors in haematological malignancies. British Journal of Haematology 123:1, pages 22-33.
Crossref
Julia Bohlius, Marcel Reiser, Guido Schwarzer & Andreas Engert. (2003) Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review. British Journal of Haematology 122:3, pages 413-423.
Crossref
John Nemunaitis. 1999. Clinical Applications of Cytokines and Growth Factors. Clinical Applications of Cytokines and Growth Factors 381 402 .
A. M. Stoppa, R. Bouabdallah, N. Vey, J. F. Rossi, R. Costello, J. Camerlo, G. Novakovitch, C. Chabannon, V. J. Bardou, D. Blaise, J. A. Gastaut & D. Maraninchi. 1998. The Role of Multiple Intensification in Medical Oncology. The Role of Multiple Intensification in Medical Oncology 21 31 .
Agustin Avilés, Renaldo Guzmán, Serafin Delgado, M. Jesús Nambo, Edna L. García & José C. Díaz-Maqueo. (1996) Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma. American Journal of Hematology 52:4, pages 275-280.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.